S&P 500
(-0.43%) 5 212.91 points
Dow Jones
(0.42%) 38 272 points
Nasdaq
(-1.23%) 16 532 points
Oil
(-0.68%) $77.38
Gas
(-0.19%) $2.57
Gold
(-0.52%) $2 354.20
Silver
(-3.03%) $30.58
Platinum
(0.54%) $1 043.60
USD/EUR
(-0.14%) $0.922
USD/NOK
(-0.42%) $10.49
USD/GBP
(0.01%) $0.786
USD/RUB
(0.17%) $90.41

Realtime updates for Biofrontera AG [B8F.DE]

Exchange: XETRA Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated13 May 2024 @ 11:36

2 000.00% 6.80

Live Chart Being Loaded With Signals

Commentary (13 May 2024 @ 11:36):

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma...

Stats
Today's Volume 45 797.00
Average Volume 605.00
Market Cap 20.67M
EPS €0 ( 2024-05-30 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -32.40
ATR14 €0.0360 (0.96%)

Volume Correlation

Long: -0.14 (neutral)
Short: 0.80 (moderate)
Signal:(77.067) Neutral

Biofrontera AG Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biofrontera AG Correlation - Currency/Commodity

The country flag 0.25
( neutral )
The country flag 0.27
( neutral )
The country flag 0.00
( neutral )
The country flag -0.50
( weak negative )
The country flag 0.05
( neutral )
The country flag 0.31
( neutral )

Biofrontera AG Financials

Annual 2023
Revenue: €32.25M
Gross Profit: €25.37M (78.67 %)
EPS: €-0.00580
FY 2023
Revenue: €32.25M
Gross Profit: €25.37M (78.67 %)
EPS: €-0.00580
FY 2022
Revenue: €25.74M
Gross Profit: €20.98M (81.52 %)
EPS: €-0.770
FY 2020
Revenue: €30.35M
Gross Profit: €26.81M (88.35 %)
EPS: €-0.234

Financial Reports:

No articles found.

Biofrontera AG Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Biofrontera AG

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.9490211009979 seconds
Number of API calls: 2
Number of DB calls: 8